Form 4: Director John Roese Receives Xerox Equity Grant

Xerox Holdings Corporation director John Roese was granted 87,209 deferred stock units as part of his director compensation.

Summary

• Director John Roese acquired 87,209 deferred stock units (DSUs) on May 20, 2026.
• The DSUs were granted at a price of $0 per unit as part of director compensation.
• The total beneficial ownership for the director following this transaction is 160,431 units.
• The balance includes 2,941 DSUs awarded from dividend equivalents.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine regulatory disclosure regarding director compensation with no material impact on company operations or financial strategy.

Positives

• Alignment of director interests with shareholders through equity-based compensation.
• Increase in total beneficial ownership by the director.

Negatives

• None identified in this filing.

Risks

• Value of the equity grant is subject to future fluctuations in Xerox Holdings Corporation common stock price.

Future Outlook

The deferred stock units are scheduled to vest on May 20, 2027, and represent the right to receive common stock upon termination of service or death.

Industry Context

StockSavvy.ai notes that equity-based compensation for board members is a standard corporate governance practice designed to align director incentives with long-term shareholder value.

Comparison to Industry Standards

• The use of deferred stock units for director compensation is consistent with standard practices among S&P 500 companies.
• The vesting period of one year is typical for annual director equity grants.

Stakeholder Impact

• Increased alignment between director and shareholder interests.

Next Steps

• Vesting of the 87,209 deferred stock units on May 20, 2027.

Key Dates

Keywords

Xerox, XRX, Form 4, Director Compensation, Equity Grant, Insider Ownership